メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
九州大学 Pure ポータルサイト ホーム
English
日本語
九州大学 Pure ポータルサイトでコンテンツを検索
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
活動
プレス/メディア
受賞
油症ダイオキシン研究診療センター
国立大学法人 九州大学
九州大学病院
概要
フィンガープリント
ネットワーク
プロファイル
(5)
研究成果
(268)
フィンガープリント
油症ダイオキシン研究診療センターが活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Immunology and Microbiology
Amino Terminal Sequence
7%
Antimicrobial Peptides
7%
Atopic Dermatitis
99%
Axon
5%
B Lymphocyte Subpopulation
5%
Back
5%
Baculoviridae
5%
Bombyx Mori
5%
Bone Marrow Derived Dendritic Cell
12%
Cardiovascular System
6%
CCL17
6%
CCL20
13%
CCL22
9%
CD34
5%
Cell Adhesion Proteins
5%
Chemokine
10%
Chickenpox
5%
Comorbidity
5%
Connective Tissue
5%
Cytokine
37%
Dendritic Cell
11%
Dermatitis
42%
Dioxygen
6%
Dupilumab
8%
Dynamic Nuclear Polarization
5%
Endothelin
11%
Epidermal Growth Factor
5%
Fibroblast
17%
Food Allergen
5%
Galactomyces
10%
Gamma Chemokine
6%
Gamma Urogastrone
5%
Gene Expression System
5%
Homeostasis
7%
Imiquimod
11%
Immunocompetent Cell
12%
Immunoglobulin E
5%
Immunosuppressant
5%
In Vitro
9%
Infancy
5%
Inflammation
22%
Innate Immune System
5%
Interferon Type I
5%
Interleukin 1
17%
Interleukin 13
27%
Interleukin 17
16%
Interleukin 23
6%
Interleukin 31
5%
Interleukin 33
7%
Interleukin 37
10%
Interleukin 4
28%
Interleukin 8
5%
Interleukin-33
13%
Keratinocyte
100%
Keratinocyte Proliferation
5%
Kinase
15%
Lupus Erythematosus
5%
Lupus Vulgaris
5%
Macrophage Derived Chemokine
5%
Melanogenesis
5%
Mite
6%
Natural Killer Cell
5%
Nectin
5%
Nerve Sprouting
5%
NLRP3 Inflammasome
5%
Normal Human
26%
Opuntia Ficus-Indica
5%
Oxidative Stress
9%
Particulate Matter
5%
Phosphodiesterase-4 Inhibitor
5%
Phosphotransferase
15%
Platelet
5%
Proline
5%
Protein Expression
8%
RANTES
5%
Regulatory T Cell
5%
Rheumatoid Nodule
5%
Ribonucleic Acid
8%
Secretion (Process)
9%
Semaphorin 3A
5%
Signal Transduction
7%
Squamous Cell
16%
Squamous Cell Carcinoma Cell
6%
Substance P
5%
Systemic Lupus Erythematosus
6%
Systemic Scleroderma
8%
Therapeutic Target
17%
Thymus and Activation Regulated Chemokine
6%
Transcription Factor Nrf2
13%
Transcription Factor RUNX2
6%
Transcription Factors
6%
Tumor Necrosis Factor
14%
Ubiquitins
5%
Upregulation
19%
Varicella Zoster Virus
5%
Wound Healing
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
5%
Adverse Event
14%
Alternariosis
5%
Antiallergic Drug
5%
Antiinflammatory Activity
5%
Antioxidant
15%
Aromatic Hydrocarbon
5%
Aromatic Hydrocarbon Receptor
83%
Atopic Dermatitis
73%
Baicalein
5%
Benzo(a)pyrene
7%
Biological Marker
10%
Bite
5%
Carbazole Derivative
12%
Carcinogenicity
5%
Cathepsin K
5%
Cell Adhesion Proteins
5%
Chemotherapy Regimens
6%
Chloracne
12%
Chronic Urticaria
5%
Clinical Trial
7%
Cohort Study
5%
Colestilan
5%
Corticotropin
5%
Cynaropicrin
10%
Cytochrome P450 1A1
5%
Cytokine
11%
Darier's Disease
5%
Dermatitis
16%
Dibenzofuran
5%
Difamilast
5%
Dioxins and Dioxin-Like Compounds
74%
Diseases
11%
Dopamine
5%
Dupilumab
5%
Eczema
11%
Epidermal Growth Factor Receptor 3
5%
Filaggrin
19%
Galactomyces
16%
Gloydius blomhoffii
5%
Hyperpigmentation
9%
Inflammation
17%
Interleukin 1
5%
Interleukin 31
5%
Interstitial Collagenase
5%
Keishi Bukuryo Gan
6%
Ketoconazole
5%
Lipid
6%
Loricrin
9%
Luliconazole
5%
Matrigel
5%
Melanoma
7%
Microtubule Associated Protein
5%
Mitogen Activated Protein Kinase
12%
Mucin 5AC
5%
Nectin
10%
Neoplasm
11%
Neurotransmitter
5%
Nivolumab
5%
Normal Human
9%
Opuntia Ficus-Indica
5%
Paget Skin Disease
11%
Palladium
5%
Palladium Nanoparticle
5%
Pathogenesis
6%
Perillaldehyde
5%
Peroxisome Proliferator Activated Receptor
10%
Phosphodiesterase IV
5%
Phosphodiesterase IV Inhibitor
5%
Platinum Nanoparticle
5%
Polychlorinated Biphenyl
20%
Polychlorinated Dibenzofuran
14%
PPAR Agonist
5%
Proline Rich Protein
5%
Protein Kinases
5%
Pruritus
13%
Pseudallescheriasis
5%
Pseudoxanthoma Elasticum
5%
Psoriasis
13%
Psoriasis Vulgaris
5%
Pustular Psoriasis
5%
RANTES
5%
Reactive Oxygen Metabolite
15%
Receptor
14%
Restless Legs Syndrome
5%
Skin Cancer
7%
Skin Carcinoma
5%
Skin Defect
5%
Skin Lupus Erythematosus
5%
Snakebite
5%
Squamous Cell Carcinoma
5%
Standardized Mortality Ratio
5%
Tapinarof
33%
Toxic Injury
6%
Transcription Factor Nrf2
20%
Tryptophan
12%
Warfarin
5%
Wasting Syndrome
5%
Yokukansan
5%
Yusho Disease
5%
Medicine and Dentistry
Adverse Event
6%
Angioimmunoblastic T-Cell Lymphoma
5%
Antimalarial
5%
Antioxidant
5%
Aromatic Hydrocarbon Receptor
31%
Atopic Dermatitis
40%
Autoimmunity
5%
Basal-Cell Carcinoma
8%
Biological Marker
6%
Bullous Pemphigoid
6%
Cancer
10%
Carbazole Derivative
6%
Cell Differentiation
5%
Cell Proliferation
6%
Chemotherapy
11%
Chloracne
10%
Clinical Symptom
5%
Connective Tissue Disease
5%
Corticotropin
5%
Dermatofibroma
5%
Dermatomycosis
5%
Dermis
15%
Differential Diagnosis
8%
Dioxin
15%
Disease Specific Survival
5%
Diseases
13%
Drug Eruption
5%
Eczema
8%
Erythema
12%
Event Free Survival
5%
Exanthem
9%
Extramammary Paget's Disease
32%
Filaggrin
11%
Hair Follicle
8%
Helicobacter Infection
5%
Hyperpigmentation
6%
Immune Checkpoint Inhibitor
12%
Immune-Related Adverse Events
9%
Inflammation
7%
Interstitial Collagenase
5%
Keishi Bukuryo Gan
6%
Keratinocyte
23%
Linear Scleroderma
5%
Magnetic Resonance Imaging
9%
Malignant Neoplasm
9%
MALT Lymphoma
5%
Medical History
8%
Melanogenesis
6%
Melanoma
30%
Minocycline
5%
Mitogen Activated Protein Kinase 1
5%
Nail
5%
Negative Pressure Wound Therapy
6%
Neoplasm
36%
Nerve Growth Factor
5%
Oral
12%
Papule
8%
Pediatrics
5%
Peroxisome Proliferator Activated Receptor
16%
Phosphotransferase
5%
Phototherapy
6%
Physical Examination
5%
Pilomatricoma
10%
Plantar Fibromatosis
5%
Polyarteritis nodosa
5%
Polychlorinated Biphenyl
10%
Prednisolone
11%
Prevalence
5%
Protein Kinases
5%
Pseudoxanthoma Elasticum
5%
Pulmonary Embolism
5%
Pyoderma gangrenosum
5%
Radiation Therapy
14%
Rhinophyma
5%
Sebaceous Carcinoma
10%
Sebaceous Gland
10%
Skin Defect
15%
Skin Injury
5%
Skin Water Loss
8%
Squamous Cell Carcinoma Antigen
5%
STEVENS-JOHNSON SYNDROME
5%
Subcutaneous Tissue
9%
Sudomotor
10%
Sweat Gland Carcinoma
10%
Systemic Scleroderma
8%
Tapinarof
16%
Targeted Therapy
6%
Therapeutic Agent
6%
Therapeutic Target
13%
Thigh
6%
Tinea Capitis
5%
Topical Drug Administration
6%
Transcription Factor Nrf2
5%
Treatment Outcome
5%
Trichophyton
5%
Trunk
15%
Tumor
14%
Tumor Cell
13%
Ulcer
5%
Vascular Surgery
5%